Share buyback program – Ipsen reporting from 11 July to 15 July 2022 – Detailed
Share buyback program – Ipsen reporting from 11 July to 15 July 2022 – Detailed
This article or press release has no online content. Please download the associated documents for more information.
Attachment

Share buyback program – Ipsen reporting from 11 July to 15 July 2022 – Detailed
This article or press release has no online content. Please download the associated documents for more information.
Attachment

Related Press Releases
Ipsen and Foreseen Biotechnology announce exclusive global licensing agreement for...
IPSEN – Buy-back programme – Art 5 of MAR –...
Ipsen – June 2024 – Monthly information relative to the...
Half-year statement of IPSEN liquidity agreement – 2024 06 30
IPSEN – Buy-back programme – Art 5 of MAR –...
Ipsen expands collaboration and license agreement for development of Cabometyx®...
IPSEN – Buy-back programme – Art 5 of MAR –...
IPSEN – Buy-back programme – Art 5 of MAR –...
IPSEN – Buy-back programme – Art 5 of MAR –...
Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class...